Correction: Targeting DORIS Remission and LLDAS in SLE: A Review.

This correction notice addresses minor errors in the original article titled "Targeting DORIS Remission and LLDAS in SLE: A Review." The errors pertain to the definition of DORIS remission and the data presented in Tables 1 and 3. The corrected definition of DORIS remission includes achieving a clinical SLEDAI-2K = 0 and a Physician's Global Assessment (PGA) < 0.5, irrespective of serology, with the use of antimalarials, low-dose glucocorticoids, and/or stable doses of immunosuppressants. The updated data in Table 3 shows changes in the number and percentage of patients achieving DORIS remission in the placebo group, as well as updated odds ratios and p-values for the comparison between treatment groups. The original article has been corrected. [Extracted from the article]